Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
GTBP - GT Biopharma, Inc.
Market Cap 10.48M P/E - EPS this Y - Ern Qtrly Grth -
Income -11.35M Forward P/E -0.82 EPS next Y - 50D Avg Chg -7.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -66.00%
Dividend N/A Price/Book 0.79 EPS next 5Y - 52W High Chg -91.00%
Recommedations 2.00 Quick Ratio 2.46 Shares Outstanding 2.23M 52W Low Chg 56.00%
Insider Own 6.44% ROA -60.59% Shares Float 1.79M Beta 0.62
Inst Own 60.09% ROE -131.48% Shares Shorted/Prior 9.28K/16.84K Price 0.28
Gross Margin - Profit Margin - Avg. Volume 591,711 Target Price -
Oper. Margin - Earnings Date Oct 30 Volume 191,875 Change 6.87%
Healthcare | Biotechnology | United States
About GT Biopharma, Inc.

GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate that is in Phase I clinical trial for the treatment of myelodysplastic syndromes, refractory/relapsed acute myeloid leukemia or advanced systemic mastocytosis, and CD33+ malignancies. The company is developing GTB-3650, which is in preclinical studies that target CD33 on the surface of myeloid leukemias; and GTB-5550 that is in preclinical studies for treating patients with B7-H3 positive solid tumors. GT Biopharma, Inc. has a co-development partnership agreement with Altor BioScience Corporation for the clinical development of a 161533 (GTB-3550) TriKE fusion protein for cancer therapies; and a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies using TriKE technology. The company was formerly known as OXIS International, Inc. and changed its name to GT Biopharma, Inc. in July 2017. GT Biopharma, Inc. was incorporated in 1965 and is based in Brisbane, California.

GT Biopharma, Inc. News
08/14/24 GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
06/27/24 GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia
05/21/24 GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
05/15/24 GT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
03/26/24 GT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Results
02/01/24 GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split
12/06/23 Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholders
12/04/23 GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia
11/06/23 GT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
11/01/23 GT Biopharma Reports Third Quarter 2023 Financial Results
GTBP Chatroom

User Image PenkeTrading Posted - 1 week ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of GT Biopharma Inc. Is that bullish or bearish? $GTBP #GTBP #nasdaq #tradingsignals #technicalanalysis

User Image Sidd_F Posted - 1 week ago

$GTBP going to have to do another reverse split next year

User Image gghh11 Posted - 1 week ago

$GTBP New ATL! The boobs that run this “company” are criminals!!

User Image cninc Posted - 2 weeks ago

$GTBP I'll say it again since last post disappeared

User Image Sidd_F Posted - 1 month ago

$GTBP now in litigation with the previous CEO and previous two CFOs. Nice work Breen.

User Image Stock_Titan Posted - 1 month ago

$GTBP GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/GTBP/gt-biopharma-reports-second-quarter-2024-financial-results-and-i6zwe5odm1ep.html

User Image smeegle3200 Posted - 1 month ago

$GTBP

User Image PenkeTrading Posted - 1 month ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of GT Biopharma Inc. Is that bullish or bearish? $GTBP #GTBP #nasdaq #tradingsignals #technicalanalysis

User Image NVDAMillionaire Posted - 1 month ago

$GTBP GT Biopharma, Inc. (NASDAQ:GTBP): Advancing Innovative Immuno-Oncology Therapies http://beyondspx.com/2024/08/01/gt-biopharma-inc-nasdaqgtbp-advancing-innovative-immuno-oncology-therapies/

User Image PennyStocksMom Posted - 2 months ago

✅️ potential swing ideas 💡 ✅️ $GTBP drop back to near 52wk low from recent high above $10 on FDA clearance for IND application, recent offering on 5/21 price $4.35, does have another active mixed shelf filed 6/20, upcoming catalyst: 1) phase 1 trial for GTB-3650 to start 2nd half 2024, 2) first half 2025 initial clinical data for phase 1 for its GTB-3650 treatment for leukemia, company focuses on developing and commercializing innumo-oncology therapeutic products ✅️ $RIME back to near 52wk low from recently high above 2, recently announced completion of SemiCab acquisition, small float, previously announced receiving $2m senior credit facility, previously announced licensing deal with Zhuhai to sell Karaoke products in China ✅️ $NVDA call 128 7/26 . Support 127. Don't forget stop loss ✅️ $DJT call 45 7/26 . Support 40. Don't forget stop loss

User Image NVDAMillionaire Posted - 2 months ago

$GTBP GT Biopharma: Advancing Innovative Immuno-Oncology Therapies with Promising TriKE® Platform http://beyondspx.com/2024/07/11/gt-biopharma-advancing-innovative-immuno-oncology-therapies-with-promising-trike-platform/

User Image RollingDollars Posted - 2 months ago

$GTBP

User Image falconfly1 Posted - 2 months ago

$EYEN $EBS and $RNA and $GTBP and $CARA What is new and opportunity in $EYEN? 1 - Insider bought 1.5 million shares in July and paid 1 Million dollars 2 - Vanguard biggest institution in the world bought 5 million dollars for a call option 3 - First FDA MydCombi selling from April 2024, and they have a contract with Vision Source biggest Private Practice Optometrists in the USA and Canada. Vision Source multi a billion company. 4 - Second FDA's strongest eyedrop sales start the first of August and are expected to generate 15 to 40 per quarter. 5 - 8 or 9 August earnings call, and it should be good. 6 - MicroPine and MicroLine are unmet need eyedrops for children and the result is coming in Q4 2024.

User Image Dr_Monkeybreath Posted - 2 months ago

$GTBP will melt faces someday. 🫠🚀💰💰💰💰

User Image RollingDollars Posted - 2 months ago

$GTBP

User Image Dr_Monkeybreath Posted - 2 months ago

@Pharmbird why not $PULM or $GTBP ?

User Image Dr_Monkeybreath Posted - 2 months ago

$TCBP 👀 $GTBP in the same space, trading under cash (enough til 2025), better SS and just approved by FDA to begin new trials this year. i mentioned it here a few times before it spiked in late May. now it's even cheaper. be a shame to miss out on the same opportunity twice.🤷‍♂️💰💰💰

User Image Dr_Monkeybreath Posted - 2 months ago

$GTBP 1,600 @ $2.75 🔒

User Image Dean3326 Posted - 2 months ago

$GTBP out for a 30% loss. No volume …. Just keeping me from making money elsewhere.

User Image Dr_Monkeybreath Posted - 2 months ago

$GTBP back in with my first 1,000 @ $2.77. 😁

User Image Dean3326 Posted - 2 months ago

$GTBP it would take so little to get this to move up. But we just have no buyers, no volume whatsoever….

User Image aa456 Posted - 2 months ago

$GTBP

User Image Dean3326 Posted - 06/28/24

$GTBP gonna be honest… I only want $5

User Image Moondy Posted - 06/28/24

$GTBP 30 days ago they squeezed this to $10+. Round two incoming.. when we see 5 million volume this is above 6 dolla

User Image Moondy Posted - 06/28/24

$GTBP Back over $3 soon, Buy the dip sell the rip. Easy

User Image aa456 Posted - 06/28/24

$GTBP

User Image Dean3326 Posted - 06/28/24

$GTBP open at $3.50 for no reason please.

User Image Dean3326 Posted - 06/28/24

$GTBP need some love today. Call any whales you know.

User Image Moondy Posted - 06/27/24

@Pharmbird $GTBP Thank me later..

User Image Moondy Posted - 06/27/24

$GTBP happy to be here before the move. Thanks for the Low volume day market. Cheers bulls, see you at $6+

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Breen Michael Martin Executive Chairman/I.. Executive Chairman/Interim CEO Apr 11 Buy 0.50 50,000 25,000 656,218 04/11/23
Ohri Manu CFO & Secretary CFO & Secretary Apr 06 Buy 0.50 50,000 25,000 50,000 04/10/23